Antimicrobial, Synergistic, and Antibiofilm Activity of Sildenafil Against Pseudomonas aeruginosa: Preliminary Studies

The present study tested sildenafil citrate as an example of pharmacological repositioning against the opportunistic pathogen Pseudomonas aeruginosa, known for its potent biofilm formation. We evaluated its antimicrobial, synergistic, and antibiofilm effects using broth microdilution, checkerboard a...

Full description

Saved in:
Bibliographic Details
Published inApplied sciences Vol. 14; no. 22; p. 10089
Main Authors Barin, Thais de Moraes, Alves, Camilla Filippi dos Santos, Teixeira, Cristiane Antunes, Verdi, Camila Marina, Moreira, Kelly Schneider, Burgo, Thiago, Novais, Vitória Fernanda Belmonte, Vaucher, Rodrigo de Almeida, Santos, Roberto Christ Vianna
Format Journal Article
LanguageEnglish
Published 05.11.2024
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present study tested sildenafil citrate as an example of pharmacological repositioning against the opportunistic pathogen Pseudomonas aeruginosa, known for its potent biofilm formation. We evaluated its antimicrobial, synergistic, and antibiofilm effects using broth microdilution, checkerboard assays, and atomic force microscopy techniques. Sildenafil citrate showed antimicrobial activity, effectively inhibiting bacterial growth at minimum inhibitory concentrations ranging from 3.12 to 6.25 mg/mL and minimum bactericidal concentrations between 3.12 and 25 mg/mL. When combined with reference antimicrobial agents—cefepime, imipenem, cilastatin, and polymyxin—sildenafil citrate had a synergistic effect. It also effectively inhibited and eradicated biofilms, reducing total biomass by 87.1% for inhibition and 83.8% for eradication. Atomic force microscopy confirmed the efficacy of sildenafil citrate in destroying and inhibiting biofilms, decreasing the overall amplitude of the biofilm. Consequently, sildenafil citrate appears to be a promising candidate for combination with commercial antimicrobial drugs to prevent and treat P. aeruginosa infections.
ISSN:2076-3417
2076-3417
DOI:10.3390/app142210089